Vaxcyte (PCVX) News Today $32.04 +0.84 (+2.69%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Vaxcyte, Inc. (NASDAQ:PCVX) Shares Acquired by Russell Investments Group Ltd.Russell Investments Group Ltd. boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 37.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 108,389 shares of the company's stock after bApril 14 at 4:31 AM | marketbeat.comCenterBook Partners LP Takes Position in Vaxcyte, Inc. (NASDAQ:PCVX)CenterBook Partners LP bought a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 23,367 shares of the company's stock, valued at approximately $1,913,000. A number ofApril 13 at 6:10 AM | marketbeat.comVaxcyte, Inc. (PCVX): Billionaire Stanley Druckenmiller’s Top Stock Pick with Huge Upside PotentialApril 11 at 6:22 PM | msn.comFederated Hermes Inc. Lowers Stake in Vaxcyte, Inc. (NASDAQ:PCVX)Federated Hermes Inc. decreased its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 34.9% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 326,058 shares of the company's stock after selling 174,992 shares during the period. Federated HApril 11 at 5:34 AM | marketbeat.comVaxcyte (NASDAQ:PCVX) Hits New 12-Month Low - What's Next?Vaxcyte (NASDAQ:PCVX) Hits New 1-Year Low - What's Next?April 11 at 4:48 AM | marketbeat.comVaxcyte (NASDAQ:PCVX) Shares Down 10% - What's Next?Vaxcyte (NASDAQ:PCVX) Trading Down 10% - What's Next?April 10, 2025 | marketbeat.comNeedham & Company LLC Reaffirms "Buy" Rating for Vaxcyte (NASDAQ:PCVX)Needham & Company LLC reissued a "buy" rating and set a $90.00 target price on shares of Vaxcyte in a report on Tuesday.April 10, 2025 | marketbeat.comFmr LLC Sells 2,709,019 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Fmr LLC trimmed its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 17.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 13,091,648 shares of the company's stock after selling 2,709,019 shares duringApril 10, 2025 | marketbeat.comTrexquant Investment LP Decreases Position in Vaxcyte, Inc. (NASDAQ:PCVX)Trexquant Investment LP trimmed its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 17.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 66,249 shares of the company's stock after selling 13April 7, 2025 | marketbeat.comGeode Capital Management LLC Boosts Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Geode Capital Management LLC boosted its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 3.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 2,802,888 shares of the company's stock after purchasing an additional 102,106 shares duringApril 7, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Schroder Investment Management GroupSchroder Investment Management Group raised its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 211.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 44,818 shares ofApril 7, 2025 | marketbeat.comVaxcyte (NASDAQ:PCVX) Trading 4.1% Higher - Still a Buy?Vaxcyte (NASDAQ:PCVX) Trading 4.1% Higher - Still a Buy?April 6, 2025 | marketbeat.comEquities Analysts Set Expectations for Vaxcyte Q1 EarningsVaxcyte, Inc. (NASDAQ:PCVX - Free Report) - Research analysts at Leerink Partnrs dropped their Q1 2025 EPS estimates for shares of Vaxcyte in a research report issued on Tuesday, April 1st. Leerink Partnrs analyst D. Risinger now expects that the company will earn ($1.07) per share for the quarteApril 5, 2025 | marketbeat.comVaxcyte (NASDAQ:PCVX) Upgraded by Evercore ISI to "Strong-Buy" RatingEvercore ISI raised Vaxcyte to a "strong-buy" rating in a research note on Monday.April 5, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for Vaxcyte Q1 Earnings?April 5, 2025 | americanbankingnews.comVaxcyte (NASDAQ:PCVX) Sees Large Volume Increase - What's Next?Vaxcyte (NASDAQ:PCVX) Sees Strong Trading Volume - Here's WhyApril 4, 2025 | marketbeat.comNorges Bank Acquires Shares of 1,100,286 Vaxcyte, Inc. (NASDAQ:PCVX)Norges Bank bought a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,100,286 shares of the company's stock, valued at approximately $90,069,000. Norges Bank ownApril 4, 2025 | marketbeat.comThe Goldman Sachs Group Issues Pessimistic Forecast for Vaxcyte (NASDAQ:PCVX) Stock PriceThe Goldman Sachs Group decreased their price objective on shares of Vaxcyte from $138.00 to $100.00 and set a "buy" rating for the company in a research note on Tuesday.April 3, 2025 | marketbeat.comFranklin Resources Inc. Has $234.88 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Franklin Resources Inc. lifted its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 3.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,869,332 shares of the company's stock after purchasing an additionApril 3, 2025 | marketbeat.comAlliancebernstein L.P. Increases Position in Vaxcyte, Inc. (NASDAQ:PCVX)Alliancebernstein L.P. lifted its holdings in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 8.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,779,362 shares of the company's stock after buying an additional 133,448 shares during tApril 3, 2025 | marketbeat.comWellington Management Group LLP Sells 69,744 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Wellington Management Group LLP reduced its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 1.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 4,444,012 shares of the company's stock after selling 69,744 shares during the quarter. WellingApril 3, 2025 | marketbeat.comBofA lowers Vaxcyte price target, says selloff after infant data ‘overdone’April 2, 2025 | markets.businessinsider.comMizuho Securities Reaffirms Their Buy Rating on Vaxcyte (PCVX)April 2, 2025 | markets.businessinsider.comVaxcyte (NASDAQ:PCVX) Price Target Cut to $137.00 by Analysts at Bank of AmericaBank of America cut their price target on shares of Vaxcyte from $157.00 to $137.00 and set a "buy" rating on the stock in a report on Tuesday.April 2, 2025 | marketbeat.comVaxcyte (NASDAQ:PCVX) Price Target Lowered to $90.00 at Needham & Company LLCNeedham & Company LLC cut their price objective on Vaxcyte from $140.00 to $90.00 and set a "buy" rating for the company in a research report on Tuesday.April 2, 2025 | marketbeat.comHeadlands Technologies LLC Increases Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)Headlands Technologies LLC increased its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 41.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 39,417 shares of the company's stock after buying an additional 11,635 sharApril 2, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Clearbridge Investments LLCClearbridge Investments LLC lessened its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 4.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,102,486 shares of the company's stock afterApril 2, 2025 | marketbeat.comVaxcyte (NASDAQ:PCVX) Hits New 1-Year Low - Should You Sell?Vaxcyte (NASDAQ:PCVX) Hits New 52-Week Low - Here's WhyApril 2, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Has $6.41 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 25.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 75,472 shares of the coApril 2, 2025 | marketbeat.comVaxcyte (NASDAQ:PCVX) Shares Gap Down - Here's What HappenedVaxcyte (NASDAQ:PCVX) Shares Gap Down - Should You Sell?April 1, 2025 | marketbeat.comVaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISIApril 1, 2025 | markets.businessinsider.comVaxcyte reports topline results from VAX-24 infant Phase 2 dose-finding studyMarch 31, 2025 | markets.businessinsider.comVaxcyte plunges despite pneumonia shot results as Marks departure weighsMarch 31, 2025 | seekingalpha.comVaxcyte price target lowered to $90 from $140 at NeedhamMarch 31, 2025 | markets.businessinsider.comVaxcyte: Shares Tanking On Positive Data? Bad Time To Be A Vaccine DeveloperMarch 31, 2025 | seekingalpha.comVaxcyte: Plunge On FDA Top Regulator Resigning Generates Buying OpportunityMarch 31, 2025 | seekingalpha.comVaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding StudyMarch 31, 2025 | globenewswire.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Pictet Asset Management Holding SAPictet Asset Management Holding SA grew its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 30.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,017,845 shares of the company's stock after pMarch 31, 2025 | marketbeat.comVaxcyte, Inc. (PCVX): One of the Best Debt Free Mid Cap Stocks to Buy NowMarch 30, 2025 | finance.yahoo.comVaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 StudyMarch 30, 2025 | globenewswire.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Prudential Financial Inc.Prudential Financial Inc. raised its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 32.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 127,771 shares of the company's stock after acquiringMarch 30, 2025 | marketbeat.comVanguard Group Inc. Increases Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Vanguard Group Inc. grew its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 4.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,961,687 shares of the company's stock after purchasing an additional 521,March 30, 2025 | marketbeat.comSei Investments Co. Sells 17,535 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Sei Investments Co. decreased its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 9.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 161,682 shares of the company's stock after selling 17,535March 30, 2025 | marketbeat.comKLP Kapitalforvaltning AS Purchases Shares of 22,500 Vaxcyte, Inc. (NASDAQ:PCVX)KLP Kapitalforvaltning AS acquired a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 22,500 shares of the company's stock, valued at approximately $1,842,000. Other larMarch 29, 2025 | marketbeat.comIs Vaxcyte, Inc. (PCVX) the Best Up and Coming Stock to Buy According to Wall Street Analysts?March 27, 2025 | msn.comFox Run Management L.L.C. Buys New Position in Vaxcyte, Inc. (NASDAQ:PCVX)Fox Run Management L.L.C. bought a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 3,989 shares of the company's stock, valued at approximately $327,000. Several other hedge fuMarch 27, 2025 | marketbeat.comAmerican Century Companies Inc. Boosts Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)American Century Companies Inc. increased its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 14.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 605,267 shares of the company's stock after acquiringMarch 27, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Stock Holdings Increased by Teacher Retirement System of TexasTeacher Retirement System of Texas raised its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 42.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 32,963 shares of the company's stock after buying an additionalMarch 26, 2025 | marketbeat.comNatixis Advisors LLC Lowers Position in Vaxcyte, Inc. (NASDAQ:PCVX)Natixis Advisors LLC trimmed its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 31.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,537 shares of the company's stock after selling 7,160 shares duringMarch 26, 2025 | marketbeat.com12 Best Up and Coming Stocks to Buy According to Wall Street AnalystsMarch 26, 2025 | insidermonkey.com Remove Ads Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address PCVX Media Mentions By Week PCVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCVX News Sentiment▼1.060.86▲Average Medical News Sentiment PCVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCVX Articles This Week▼106▲PCVX Articles Average Week Remove Ads Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Teva Pharmaceutical Industries News Today Intra-Cellular Therapies News Today Summit Therapeutics News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Moderna News Today Viatris News Today Qiagen News Today Ascendis Pharma A/S News Today Roivant Sciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCVX) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PCVX Stock Free PCVX Stock Alerts